Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions-Reference-Cited by-同舟云学术

Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions

Published:2011-05-18 Issue:5 Volume:25 Page:E475-E486
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:

Author:

Epailly E.,Albanell J.,Andreassen A.,Bara C.,Campistol J.M.,Delgado J.F.,Eisen H.,Fiane A.E.,Mohacsi P.,Schubert S.,Sebbag L.,Turazza F.M.,Valantine H.,Zuckermann A.,Potena L.

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0012.2011.01476.x/fullpdf

Reference119 articles.

1. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009;Taylor;J Heart Lung Transplant,2009

2. NIH http://www.nhlbi.nih.gov/health/dci/Diseases/ht/ht_risks.html

3. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review;Gutierrez-Dalmau;Drugs,2007

4. Lymphomas after solid organ transplantation: a collaborative transplant study report;Opelz;Am J Transplant,2004

5. Post-transplant de novo malignancies in renal transplant recipients: the past and present;Kauffman;Transpl Int,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Post-Heart Transplant Malignancies: A Systematic Review and Meta-Analysis;Current Problems in Cardiology;2022-12

2. Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making;Transplant International;2021-09-27

3. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience;Transplantation Proceedings;2021-03

4. Complications After Heart Transplantation in Adults: an Update;Current Emergency and Hospital Medicine Reports;2019-04-22

5. The change of immunosuppressive regimen from calcineurin inhibitors to mammalian target of rapamycin (mTOR) inhibitors and its effect on malignancy following heart transplantation;International Immunopharmacology;2019-04